EN
DE 
NL 
FR 
ES 
IT 
CS 
PL TERPENES
The entourage effect is the idea that cannabis compounds work better together than alone. Coined to describe how cannabinoids and terpenes may interact, the entourage effect is one of the most cited and most debated ideas in cannabis science. Here is what it claims and how strong the evidence actually is.
The claim
The hypothesis is that the whole-plant mixture of cannabinoids and terpenes produces effects that differ from any single compound in isolation. In this view, terpenes and minor cannabinoids shape and soften the effect of THC and CBD, which would explain why two products with identical THC can feel different.
Where it comes from
The concept was popularised by researcher Ethan Russo, whose 2011 review argued that specific terpenes could plausibly influence mood, anxiety and other effects, and might complement cannabinoids. It built on earlier observations that isolated THC feels different from whole-plant cannabis.
How strong is the evidence
This is the honest part: the entourage effect is biologically plausible and supported by some laboratory and preclinical work, but it is not settled science. Well-controlled human trials are limited, and some studies have failed to find the predicted interactions.
Treat it as a promising, partly supported hypothesis, not an established fact. It is a good reason to pay attention to full profiles rather than THC alone, but not a basis for strong claims.
Why it still matters
Even unproven, the idea reframes cannabis usefully: it pushes attention from a single THC number toward the whole chemotype, which is exactly how this site organises knowledge.
Continue exploring
Origin of the Hypothesis and Receptor Pharmacology Evidence
The phrase "entourage effect" was coined in 1998 by Ben-Shabat, Mechoulam, and colleagues after observing that biologically inactive monoacylglycerol esters (2-linoleoylglycerol and 2-palmitoylglycerol) potentiated the binding and activity of the endocannabinoid 2-AG (PubMed PMID 9721036). In 2011, Russo extended the concept to botanical cannabis, proposing that phytocannabinoids and terpenoids exert synergistic pharmacological interactions across multiple molecular targets (PubMed PMID 21749363). However, subsequent functional receptor assays by Santiago et al. (2019) and radioligand/cAMP screening by Finlay et al. (2020) demonstrated that common cannabis terpenes neither directly activate nor allosterically modulate human CB1 or CB2 receptors at physiologically relevant concentrations, indicating that any terpene-cannabinoid interactions occur via non-CB1/CB2 pathways (PubMed PMID 31481004; PubMed PMID 32030544).
Frequently Asked Questions
Who coined the term entourage effect?
Raphael Mechoulam, Shimon Ben-Shabat, and colleagues coined the term in 1998 to describe how endogenous fatty acid esters potentiated the activity of the endocannabinoid 2-AG.
Do cannabis terpenes bind directly to CB1 or CB2 receptors?
Controlled in vitro receptor assays (Santiago et al., 2019; Finlay et al., 2020) show that major cannabis terpenes do not directly activate or allosterically modulate CB1 or CB2 receptors, except beta-caryophyllene at CB2.
What is the difference between cannabinoid-cannabinoid and terpene-cannabinoid interactions?
Cannabinoid-cannabinoid interactions (such as CBD acting as a negative allosteric modulator of CB1 alongside THC) have stronger clinical replication than proposed terpene-THC synergies.
English